Standout Papers

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, do... 2022 2026 2023 2024126
  1. Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial (2022)
    Kristian Reich, Jacob P. Thyssen et al. The Lancet

Immediate Impact

5 from Science/Nature 82 standout
Sub-graph 1 of 21

Citing Papers

Atopic dermatitis
2025 Standout
Lithium extraction from low-quality brines
2024 StandoutNature
1 intermediate paper

Works of Fernando Valenzuela being referenced

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
2022 Standout
Extraction of molybdenum by a supported liquid membrane method
2003

Author Peers

Author Last Decade Papers Cites
Fernando Valenzuela 509 528 405 114 2.1k
Zhe Cai 360 118 282 100 2.4k
Takao Fujii 556 130 54 142 3.0k
Xiaochen Gu 88 401 40 67 2.5k
Shayne C. Gad 234 251 31 107 2.3k
Noriaki Nagai 113 136 24 219 2.4k
Jung‐Hoon Kim 170 70 75 157 2.5k
Wei‐Ting Liao 288 192 32 125 2.2k
Götz Westphal 319 356 43 52 1.7k
Ning Zhao 317 21 151 99 2.6k
Yasuo Asada 121 400 18 129 2.8k

All Works

Loading papers...

Rankless by CCL
2026